Survey Reveals Widespread Usage of GLP-1 Drugs
About one in eight American adults are now taking GLP-1 drugs like Ozempic, Wegovy, Zepbound, and Mounjaro, a new survey shows—a sharp increase from just 18 months ago. These medications, approved in the US only four years ago for obesity, are quickly becoming some of the most widely prescribed,…
Lactalis enters the GLP-1 race
Bariatric Surgery vs GLP-1 Medications like Ozempic or Mounjaro: Bariatric Surgeon Dr. David G. Davtyan of Weight Loss Surgery Los Angeles Weighs In on Real-World Results
Dr. David G. Davtyan of Weight Loss Surgery Los Angeles discusses how bariatric surgery continues to outperform GLP-1 medications in achieving long-term, sustainable weight loss. The release educates patients on personalized treatment options and the importance of expert evaluation before…
Novo cuts Wegovy prices, but doctors still see cost challenges for patients
By TOM MURPHY, Associated Press Health Writer Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients without insurance. Related Articles House explosion in Southern California injures 8 and damages nearby homes New analysis shows more US consumers are falling behind on their utility bills Today in […]
Novo Undercuts Lilly’s Obesity Drug Price, Now Cheaper Than Car Payment
Novo Undercuts Lilly’s Obesity Drug Price, Now Cheaper Than Car Payment Just before the US cash session, Novo Nordisk A/S announced it will slash prices on Wegovy and Ozempic in a direct challenge to Eli Lilly’s obesity drug, aiming to regain market share. The announcement comes just weeks after President Trump finalized a deal with Novo […]
Popstar Robbie Williams warns of GLP-1 vision loss – here’s why it matters for F&B
Robbie Williams warns GLP-1 drugs may cause vision loss. What does this mean for food & beverage innovation and natural alternatives?
STAT+: Pharmalittle: We’re reading about Novo plans for Wegovy, a Purdue bankruptcy deal, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-familiar routine of meetings, deadlines, and messages has returned. But what can you do? There is no pause button to stop the world from spinning. So this means one thing: time to dig in to […]
GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®
SANTA MONICA, Calif.–(BUSINESS WIRE)–GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced two major initiatives to make FDA-approved GLP-1 medications more widely available. First, the launch of GoodRx for Weight Loss, a telemedicine subscription that connects consumers to licensed healthcare providers for affordable weight management treatment. Second, in partnership with […]
Novo Nordisk Cuts Prices for Obesity Drugs
The lower costs come months before a pricing deal with Trump takes effect Novo NordiskNOVO.B-1.43%decrease; red down pointing triangle slashed prices for its obesity drugs months before an agreement with the Trump administration mandating that it lower its GLP-1 prices takes effect. The Denmark-based …
Novo Nordisk slashes out-of-pocket prices for Wegovy and Ozempic
The Danish drugmaker said it’s cutting the price of Wegovy and Ozempic from $499 to $349 per month for some customers who buy the drugs directly.